DENVER, June 1, 2021 /PRNewswire/ — Paragon 28, Inc., a market-leading orthopedic medical device company focused exclusively on the foot-and-ankle, today announced that the Company has acquired the product lines of Additive Orthopaedics (“Additive”). The Additive 3D-printed Patient Specific Talus Spacer was approved on February 17, 2021 by the US Food and Drug Administration (“FDA”) and is the first...
ENGLWOOD, Colo., May 20, 2021 /PRNewswire/ — Paragon 28 is pleased to announce the launch of the BEAST™ Injectable Putty, BEAST PLUS™, and BEAST™ Osteobiologic Sponge (BOB™)! All three grafts have a high osteoinductive potential, excellent handling characteristics, and are processed using a proprietary method which ensures preservation of native bone morphogenic proteins (BMP), notably 2,...
DENVER, May 17, 2021 /PRNewswire/ — Paragon 28, Inc. a market leading orthopedic medical device company focused exclusively on the foot and ankle, today announced that the Company has entered into a credit facility with MidCap Financial (“MidCap”) providing Paragon 28 access up to $70 million in total credit. Read the full article here.
ENGLEWOOD, Colo., May 12, 2021 /PRNewswire/ — Paragon 28, Inc. continues to revolutionize the Orthopedic Total Ankle Joint Replacement (TAR) market by successfully introducing the FasTrac™ Distal Tibia Alignment System, featuring proprietary laser technology developed to provide a precise visual reference point during component alignment, a critical step in establishing optimal implant placement during TAR procedures....
ENGLEWOOD, Colo., May 4, 2021 /PRNewswire/ — Paragon 28, Inc. unveils the highly anticipated MAVEN™ PSI System, a platform technology thoughtfully designed to expedite accurate positioning of the APEX 3D™ Total Ankle Replacement System. MAVEN PSI advances patient-specific technologies with anatomical design features promoting alignment accuracy, stability, and ideal implant placement. MAVEN PSI is compatible...
Paragon 28, Inc. announced today that Stephen Oesterle, M.D. has joined its Board of Directors. “Dr. Oesterle adds extensive experience to our board as both a physician and executive leader at one of the world’s largest medical technology companies,” said Albert DaCosta, Co-Founder, President and Chief Executive Officer, Paragon 28. “We are delighted Steve has...
Paragon 28, Inc., a leading orthopedic foot and ankle company, today announced the completion of a Series B financing. The round was co-led by Piper Sandler Merchant Banking, a commercial stage growth equity investment business of Piper Sandler Companies, and MVM Partners, a healthcare growth equity investment firm. The financing also included participation from an...
Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefiting both the surgeon and patient. Today...
APEX 3D™ marks the next generation in Total Ankle Arthroplasty, with advanced technologies such as porous 3D printed implants and Vitamin E infused highly cross-linked polyethylene. Paragon 28 conducted cutting-edge biomechanical research, including a CT study of arthritic ankles to determine implant geometry and sizing, and a weightbearing CT study of healthy ankles to best...
Paragon 28® launched the TenoTac® Soft Tissue Fixation System in January 2019, providing surgeons the first and only dedicated system to address tendon transfers of the forefoot to correct contracted toes and repair plantar plate. In contrast to traditional methods for flexor tendon transfers, TenoTac® facilitates correction without releasing tissue attachments distally by balancing plantar...
The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.
© 2024 Paragon 28, Inc.
